ImmuPharma plc (AIM:IMM)
London · Delayed Price · Currency is GBP · Price in GBX 4.390
+0.290 (7.07%)
Aug 14, 2026, 4:45 PM GMT
ImmuPharma Market Cap
ImmuPharma has a market cap or net worth of 27.39 million as of August 14, 2026. Its market cap has increased by 241.49% in one year.
Market Cap
27.39M
Enterprise Value
26.04M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.39
ChartMarket Cap Chart
Since February 22, 2006, ImmuPharma's market cap has decreased from 36.11M to 27.39M, a decrease of -24.16%. That is a compound annual growth rate of -1.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 27.39M | -12.12% |
| Dec 31, 2025 | 31.17M | 521.13% |
| Dec 31, 2024 | 5.02M | -27.71% |
| Dec 29, 2023 | 6.94M | 13.16% |
| Dec 30, 2022 | 6.13M | -62.85% |
| Dec 31, 2021 | 16.51M | -50.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| hVIVO | 46.03M |
| Hemogenyx Pharmaceuticals | 42.16M |
| Sareum Holdings | 35.33M |
| SkinBioTherapeutics | 26.56M |
| Arecor Therapeutics | 22.47M |
| IXICO | 16.35M |
| Aptamer Group | 14.68M |
| Palatin Technologies | 13.96M |